Ranking the effectiveness of autologous blood conservation measures through validated modeling of independent clinical data

Transfusion

Volumn 53, Issue 12, 2013, Pages 3060-3079

  Singbartl, Günter ^a   Held, Anna Lena ^a   Singbartl, Kai ^a  

^a Krankenhaus Salzhausen   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; IRON; PLACEBO; RECOMBINANT ERYTHROPOIETIN;

ACUTE NORMOVOLEMIC HEMODILUTION; ARTICLE; BLEEDING; BLOOD AUTOTRANSFUSION; BLOOD CONSERVATION; BLOOD VOLUME; CLINICAL EFFECTIVENESS; ERYTHROCYTE TRANSFUSION; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HUMAN; INTERMETHOD COMPARISON; INTRAOPERATIVE BLOOD SALVAGE; MATHEMATICAL MODEL; PREOPERATIVE AUTOLOGOUS DEPOSIT;

BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION, AUTOLOGOUS; HEMODILUTION; HUMANS; MODELS, THEORETICAL; OPERATIVE BLOOD SALVAGE; TRANSPLANTATION, HOMOLOGOUS;

EID: 84890437988     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12233     Document Type: Article

References (70)

1. Zou S, Musavi F, Notari EP, Fang CT,; ARCNET Research Group. Changing age distribution of the blood donor population in the United States. Transfusion 2008; 48: 251-257.
2. Sullivan MT, Cotten R, Read EJ, Wallace EL,. Blood collection and transfusion in the United States in 2001. Transfusion 2007; 47: 385-394.
3. Greinacher A, Fendrich K, Alpen U, Hoffmann W,. Impact of demographic changes on the blood supply: Mecklenburg-West Pomerania as a model region for Europe. Transfusion 2007; 47: 395-401.
4. Greinacher A, Fendrich K, Hoffmann W,. Demographic changes: the impact for safe blood supply. Transfus Med Hemother 2010; 37: 141-148.
5. Ehling M, Pötzsch O,. Demographic changes in Germany up to 2060-consequences for blood donation. Transfus Med Hemother 2010; 37: 131-139.
6. Katalinic A, Peters E, Beske F, Pritzkuleit R,. Projection of morbidity 2030 and 2050: impact for the national health system and blood supply. Transfus Med Hemother 2010; 37: 155-159.
7. Drackley A, Newbold KB, Paez A, Heddle N,. Forecasting Ontario's blood supply and demand. Transfusion 2012; 52: 366-374.
8. Currie CJ, Patel TC, McEwan P, Dixon S,. Evaluation of the future supply and demand for blood products in the United Kingdom National Health Service. Transfus Med 2004; 14: 19-24.
9. Osaro E, Njemanze C,. Challenges of meeting the future blood transfusion requirement in England and Wales. Autologous blood transfusion could become an adjunct to the UK blood transfusion program in the future. Transfus Altern Transfus Med 2010; 11: 72-81.
10. Bryson GL, Laupacis A, Wells GA,. Does acute normovolemic hemodilution reduce perioperative allogeneic transfusion? A meta-analysis. The International Study of Perioperative Transfusion. Anesth Analg 1998; 86: 9-15.
11. Forgie MA, Wells PS, Laupacis A, Fergusson D,. Preoperative autologous donation decreases allogeneic transfusion but increases exposure to all red blood cell transfusion: results of a meta-analysis. International Study of Perioperative Transfusion (ISPOT) Investigators. Arch Intern Med 1998; 158: 610-616.
12. Huët C, Salmi LR, Fergusson D, Koopman-van Gemert AW, Rubens F, Laupacis A,. A meta-analysis of the effectiveness of cell salvage to minimize perioperative allogeneic blood transfusion in cardiac and orthopedic surgery. International Study of Perioperative Transfusion (ISPOT) Investigators. Anesth Analg 1999; 89: 861-869.
13. Henry DA, Carless PA, Moxey AJ, O'Connell D, Forgie MA, Wells PS, Fergusson D,. Pre-operative autologous donation for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2002;(2): CD003602.
14. Carless P, Moxey A, O'Connell D, Henry D,. Autologous transfusion techniques: a systematic review of their efficacy. Transfus Med 2004; 14: 123-144.
15. Carless PA, Henry DA, Moxey AJ, O'Connell D, Brown T, Fergusson DA,. Cell salvage for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2010;(4): CD001888.
16. Lorentz A, Osswald PM, Schilling M, Jani L,. [A comparison of autologous transfusion procedures in hip surgery]. Anaesthesist 1991; 40: 205-213.
17. Ness PM, Bourke DL, Walsh PC,. A randomized trial of perioperative hemodilution versus transfusion of preoperatively deposited autologous blood in elective surgery. Transfusion 1992; 32: 226-230.
18. Monk TG, Goodnough LT, Brecher ME, Colberg JW, Andriole GL, Catalona WJ,. A prospective randomized comparison of three blood conservation strategies for radical prostatectomy. Anesthesiology 1999; 91: 24-33.
19. Monk TG, Goodnough LT, Birkmeyer JD, Brecher ME, Catalona WJ,. Acute normovolemic hemodilution is a cost-effective alternative to preoperative autologous blood donation by patients undergoing radical retropubic prostatectomy. Transfusion 1995; 35: 559-565.
20. Goodnough LT, Monk TG, Despotis GJ, Merkel K,. A randomized trial of acute normovolemic hemodilution compared to preoperative autologous blood donation in total knee arthroplasty. Vox Sang 1999; 77: 11-16.
21. Waters JH, Lee JS, Klein E, O'Hara J, Zippe C, Potter PS,. Preoperative autologous donation versus cell salvage in the avoidance of allogeneic transfusion in patients undergoing radical retropubic prostatectomy. Anesth Analg 2004; 98: 537-542.
22. Billote DB, Abdoue AG, Wixson RL,. Comparison of acute normovolemic hemodilution and preoperative autologous blood donation in clinical practice. J Clin Anesth 2000; 12: 31-35.
23. Singbartl G, Schreiber J, Singbartl K,. Preoperative autologous blood donation versus intraoperative blood salvage: intraindividual analyses and modeling of efficacy in 1103 patients. Transfusion 2009; 49: 2374-2383.
24. Singbartl K, Schleinzer W, Singbartl G,. Hypervolemic hemodilution: an alternative to acute normovolemic hemodilution? A mathematical analysis. J Surg Res 1999; 86: 206-212.
25. Singbartl K, Innerhofer P, Radvan J, Westphalen B, Fries D, Stogbauer R, Van Aken H,. Hemostasis and hemodilution: a quantitative mathematical guide for clinical practice. Anesth Analg 2003; 96: 929-935.
26. Brecher ME, Rosenfeld M,. Mathematical and computer modeling of acute normovolemic hemodilution. Transfusion 1994; 34: 176-179.
27. Lisander B, Enqvist A,. The gain of red-cells from preoperative hemodilution-evaluation of benefit using a mathematical-model. Theor Surg 1994; 9: 142-147.
28. Weiskopf RB,. Mathematical analysis of isovolemic hemodilution indicates that it can decrease the need for allogeneic blood transfusion. Transfusion 1995; 35: 37-41.
29. Kick O, Daniel E,. Mathematical considerations in the practice of acute normovolemic hemodilution. Transfusion 1997; 37: 141-143.
30. Engoren M,. A computer model comparing normovolemic hemodilution, hypervolemic hemodilution, and neither on intraoperative blood loss and final hematocrit. Am J Anesthesiol 1995; 22: 229-234.
31. Hay SN, Monk TG, Brecher ME,. Intraoperative blood salvage: a mathematical perspective. Transfusion 2002; 42: 451-455.
32. Waters JH, Lee JS, Karafa MT,. A mathematical model of cell salvage efficiency. Anesth Analg 2002; 95: 1312-1317.
33. Waters JH, Lee JSJ, Karafa MT,. A mathematical model of cell salvage compared and combined with normovolemic hemodilution. Transfusion 2004; 44: 1412-1416.
34. Cohen JA, Brecher ME,. Preoperative autologous blood donation: benefit or detriment? A mathematical analysis. Transfusion 1995; 35: 640-644.
35. Nadler SB, Hidalgo JH, Bloch T,. Prediction of blood volume in normal human adults. Surgery 1962; 51: 224-232.
36. Bourke DL, Smith TC,. Estimating allowable hemodilution. Anesthesiology 1974; 41: 609-612.
37. Spahn DR, Waschke KF, Standl T, Motsch J, Van Huynegem L, Welte M, Gombotz H, Coriat P, Verkh L, Faithfull S, Keipert P,; European Perflubron Emulsion in Non-Cardiac Surgery Study Group. Use of perflubron emulsion to decrease allogeneic blood transfusion in high-blood-loss non-cardiac surgery: results of a European phase 3 study. Anesthesiology 2002; 97: 1338-1349.
38. Spahn DR, Willimann PF, Faithfull NS,. [The effectiveness of augmented acute normovolemic hemodilution (A-ANH)]. Anaesthesist 2001; 50 (Suppl 1): S49-54.
39. Kemming G, Habler O, Zwissler B,. Augmented acute normovolemic hemodilution (A-ANH(tm)) in cardiac and non-cardiac patients. Anasthesiol Intensivmed Notfallmed Schmerzther 2001; 36 (Suppl 2): S107-109.
40. Singbartl G, Reibold JP, Goudschaal E, Quoss A, Munkel H,. Preoperative autologous blood donation in patients with rheumatoid arthritis: analysis on the effectiveness in increasing red blood cell mass. Infus Ther Transfus Med 2000; 27: 101-105.
41. Singbartl G, Malgorzata S, Quoss A,. Preoperative autologous blood donation-part II. Adapting the predeposit concept to the physiological basics of erythropoiesis improves its efficacy. Minerva Anestesiol 2007; 73: 153-160.
42. Singbartl G,. Preoperative autologous blood donation-part I. Only two clinical parameters determine efficacy of the autologous predeposit. Minerva Anestesiol 2007; 73: 143-151.
43. Mercuriali F, Zanella A, Barosi G, Inghilleri G, Biffi E, Vinci A, Colotti MT,. Use of erythropoietin to increase the volume of autologous blood donated by orthopedic patients. Transfusion 1993; 33: 55-60.
44. Mercuriali F, Inghilleri G, Biffi E, Colotti MT, Vinci A, Oriani G,. Epoetin alfa in low hematocrit patients to facilitate autologous blood donation in total hip replacement: a randomized, double-blind, placebo-controlled, dose-ranging study. Acta Haematol 1998; 100: 69-76.
45. Price TH, Goodnough LT, Vogler WR, Sacher RA, Hellman RM, Johnston MF, Bolgiano DC, Abels RI,. The effect of recombinant human erythropoietin on the efficacy of autologous blood donation in patients with low hematocrits: a multicenter, randomized, double-blind, controlled trial. Transfusion 1996; 36: 29-36.
46. Smith KJ, James DS, Hunt WC, McDonough W, Quintana R,. A randomized, double-blind comparison of donor tolerance of 400 mL, 200 mL, and sham red cell donation. Transfusion 1996; 36: 674-680.
47. Kasper SM, Lazansky H, Stark C, Klimek M, Laubinger R, Börner U,. Efficacy of oral iron supplementation is not enhanced by additional intravenous iron during autologous blood donation. Transfusion 1998; 38: 764-770.
48. Kasper SM, Gerlich W, Buzello W,. Preoperative red cell production in patients undergoing weekly autologous blood donation. Transfusion 1997; 37: 1058-1062.
49. Rau B, Schlag PM, Willeke F, Herfarth C, Stephan P, Franke W,. Increased autologous blood donation in rectal cancer by recombinant human erythropoietin (rhEPO). Eur J Cancer 1998; 34: 992-998.
50. Högler W, Mayer W, Messmer C, Eibl G, Innerhofer P, Schönitzer D, Nussbaumer W,. Prolonged iron depletion after allogeneic 2-unit RBC apheresis. Transfusion 2001; 41: 602-605.
51. Lee JH, Lee SH, Oh JH,. Minimal effective dosage of recombinant human erythropoietin in spinal surgery. Clin Orthop Relat Res 2003; 412: 71-76.
52. Valeri CR, Ragno G, Srey R,. Restoration of red blood cell volume following 2-unit red blood cell apheresis. Vox Sang 2003; 85: 85-87.
53. Meunier A, Petersson A, Good L, Berlin G,. Validation of a haemoglobin dilution method for estimation of blood loss. Vox Sang 2008; 95: 120-124.
54. Schwarz U,. Recombinantes, humanes Erythropoietin und seine Anwendungen in der Eigenblutspende, unter Kombination mit intravenöser Eisengabe. Germany: Ruhr-Universität Bochum; 1999.
55. Schmitz-Forte J,. Die Indikation zur präoperativen Eigenblutspende vor künstlichem Hüft- oder Kniegelenksersatz. Germany: Universität Köln; 2007.
56. Halm-Heinrich Y,. Effektivitätsunterschiede bei der präoperativen Eigenblutspende hinsichtlich der Hb-Regeneration (Konservengewinn) durch veränderte Entnahmeschema. Germany: Otto-von-Guericke Universität Magdeburg; 2004.
57. Kohlhammer Y,. Die Variabilität der kompensatorischen Erythropoese nach präoperativer Eigenblutspende: Nachweis von Antikörpern gegen potentiell hämatotrope Viren. Germany: Friedrich-Alexader-Universität Erlangen- Nürnberg; 2004.
58. Pfaffenzeller P,. Präoperative Eigenblutspende bei Patienten mit Endo-prothesenoperationen Untersuchungen an Patienten zur Akzeptanz, Komplikationsrate, Hämoglobinregeneration und Auswirkung auf die Verminderung von Fremdbluttransfusionen. Germany: Freie Universität Berlin; 1991.
59. Biesma DH, Kraaijenhagen RJ, Poortman J, Marx JJ, van de Wiel A,. The effect of oral iron supplementation on erythropoiesis in autologous blood donors. Transfusion 1992; 32: 162-165.
60. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, Clarke M, Devereaux PJ, Kleijnen J, Moher D,. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Plos Med 2009; 6: e1000100.
61. Chalmers TC, Celano P, Sacks HS, Smith H,. Bias in treatment assignment in controlled clinical trials. N Engl J Med 1983; 309: 1358-1361.
62. Davies L, Brown TJ, Haynes S, Payne K, Elliott RA, McCollum C,. Cost-effectiveness of cell salvage and alternative methods of minimising perioperative allogeneic blood transfusion: a systematic review and economic model. Health Technol Assess 2006; 10: iii-iv, ix-x, 1-210.
63. Bunn H,. Disorders of the hematopoietic system: pathophysiology of anemias. In:, Wilson SD, Braunwald E, Isselbacher KS, Petersdorf RG, Martin SB, Fanci AS, Root RK, editors. Harrison's principles of internal medicine. New York (NY): McGraw Hill Inc; 1991. p. 1514-1518.
64. Pottgiesser T, Specker W, Umhau M, Dickhuth H-H, Roecker K, Schumacher YO,. Recovery of hemoglobin mass after blood donation. Transfusion 2008; 48: 1390-1397.
65. Weisbach V, Corbière C, Strasser E, Zingsem J, Zimmermann R, Eckstein R,. The variability of compensatory erythropoiesis in repeated autologous blood donation. Transfusion 2001; 41: 179-183.
66. Hasselbring H, Weidringer G, Steinlein H,. [The effect of preoperative haemodilution from clinical and theoretical point of view (author's transl)]. Anaesthesist 1977; 26: 30-32.
67. Weidringer G, Hasselbring H, Steinlein H,. [What gains are actually attained through acute preoperative haemodilution? (author's transl)]. Anaesthesist 1976; 25: 189-192.
68. Klövekorn WP, Messmer K,. [Why are calculated "in-vitro" effects of preoperative haemodilution in variance with respective clinical findings? (author's transl)]. Anaesthesist 1976; 25: 193-194.
69. Segal JB, Blasco-Colmenares E, Norris EJ, Guallar E,. Preoperative acute normovolemic hemodilution: a meta-analysis. Transfusion 2004; 44: 632-644.
70. Habler O, Schwenzer K, Zimmer K, Prager M, König U, Oppenrieder K, Pape A, Steinkraus E, Reither A, Buchrot A, Zwissler B,. Effects of standardized acute normovolemic hemodilution on intraoperative allogeneic blood transfusion in patients undergoing major maxillofacial surgery. Int J Oral Maxillofac Surg 2004; 33: 467-475.